S. Shimizu et al., Presence of excess tetrahydrobiopterin during nitric oxide production frominducible nitric oxide synthase in LPS-treated rat aorta, LIFE SCI, 65(26), 1999, pp. 2769-2779
Tetrahydrobiopterin (BH4) is one of the cofactors of nitric oxide synthase
(NOS), and the synthesis of BH4 is induced as well as inducible NOS (iNOS)
by lipopolysaccharide (LPS) and/or cytokines. BH4 has a protective effect a
gainst the cytotoxicity induced by nitric oxide (NO) and/or reactive oxygen
species in various types of cells. The purpose of this study was to examin
e whether or not an excess of BH4 is present during the production of NO by
iNOS in LPS-treated deendothelialized rat aorta. Addition of LPS (10 mu g/
ml) to the aorta bath solution caused L-arginine (L-Arg)-induced relaxation
from 1.5 hr after the addition of LPS in de-endothelialized rat aorta pre-
contracted with 30 mM KCL. The L-Arg-induced relaxation was prevented by NO
S inhibitors. BH4 content also increased from 3 hr after the addition of LP
S. mRNAs of iNOS and GTP cyclohydrolase I (GTPCH), a rate-limiting enzyme o
f BH4 synthesis, were increased from 1.5 hr after addition of LPS. Although
the expression of iNOS and GTPCH mRNAs was observed in the media, the expr
ession levels in the media were much lower than those in the adventitia. Te
n millimolar 2,4-diamino-6-hydroxypyrimidine (DAHP), an inhibitor of GTPCH,
strongly reduced L-Arg-induced relaxation, and decreased BH4 content to be
low the basal level in LPS-treated aorta, whereas 0.5 mM DAHP reduced the L
PS-induced increase in BH4 content to the basal level but did not affect L-
Arg-induced relaxation. The inhibition of L-Arg-induced relaxation by 10 mM
DAHP was overcome by the addition of BH4 (10 mu M). These results suggest
that although BH4 is essential for NO production from iNOS, the increase in
BH4 content above the basal level is not needed for eliciting L-Arg-induce
d relaxation by the treatment with LPS. Thus, an excess amount of BH4 may b
e synthesized during NO production by iNOS in LPS-treated rat aorta.